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a b s t r a c t
Aim: To determine the effects of Vitamin C (VC-ascorbic acid) as an additive on erythro-
cytes of stored blood. Background: Oxidative stress (OS) plays a major role in the forma-
tion of storage lesion of erythrocytes. Antioxidants, such as VC could be beneficial in
combating oxidative damage during storage. Materials and methods: Blood obtained
from male Wistar rats was stored at 4 8C in anticoagulant solution citrate-phosphate-
dextrose-adenine solution. Blood samples were divided into 3 groups – (i) Controls, (ii)
VC 10 (VC at a concentration of 10 mM), (iii) VC 30 (VC at a concentration of 30 mM).
Markers of OS in erythrocytes such as – hemoglobin, superoxides, antioxidant enzymes
(superoxide dismutase; SOD, catalase and glutathione peroxidase), hemolysis, lipid pero-
xidation products (conjugate dienes and malondialdehyde), protein oxidation products
and ascorbic acid were determined on days 0, 10 and 15 of storage. Results: Addition of
ascorbic acid to the storage solution contributed to the protection of erythrocytes from
oxidative damage. Ascorbic acid at a concentration of 30 mM decreased SOD levels and
increased protein sulfhydryls (P-SH) levels on day 15 showing that higher concentration
supplemented the inherent antioxidant defense system of erythrocytes during blood sto-
rage. Conclusion: VC proved to be effective in combating OS during blood storage. Howe-
ver, further exploration of antioxidants as additives and the erythrocyte storage lesion
would result in better management of blood storage.
© 2017 Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i
Transfuzjologii. Published by Elsevier Sp. z o.o. All rights reserved.
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Blood transfusion is an acute intervention, implemented to
solve life- and health-threatening conditions on a short-
term basis, and in general its long term effects tend to be of
secondary importance [1]. Red blood cell (RBC) transfusion* Corresponding author.
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z o.o. All rights reserved.is a key element of modern medical care. The ability to
store RBCs for reasonable times clearly improves their
availability and lowers their cost [2]. Whole blood can be
stored up to a period of 35 days in anticoagulant solution
CPDA-1 (citrate, phosphate, dextrose and adenine) while
erythrocytes (RBCs) possess a shelf life of 42 days at 4 8C in
SAGM (saline, adenine, glucose and mannitol) solution [2].c.in (R. Vani).
w, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp.
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changes that may reduce function and viability after
transfusion [3]. Changes accompanying the storage of RBCs
are known as “storage lesion”. During storage of blood and
its components, in various additive solutions, it has been
found that oxidative stress (OS), influences their function-
ing, efficacy and shelf life. OS is the fundamental phenom-
enon leading to the formation of storage lesion in
erythrocytes [4–6]. Protein oxidation and lipid peroxidation
(LPO) also occur, in turn causing vesiculation and loss of
deformability [7]. OS plays an important role in the forma-
tion of storage lesions in blood and its components and
there exists an inherent antioxidant system in blood to
combat OS. However, during storage, there is a reduction in
blood antioxidant capacity, leading to increased suscept-
ibility to OS. Hence, there is a possibility of utilizing
antioxidants to aid in protecting the erythrocytes against
oxidative damage during storage.
Vitamin C (VC) or ascorbic acid is found in erythrocytes
and can scavenge a wide variety of free radicals directly in
the aqueous phase. VC reduces superoxide and lipid peroxyl
radicals, a synergistic agent for Vitamin E [8–10] and
protects membrane [11]. Ascorbic acid serves as both an
antioxidant and a prooxidant. As a prooxidant, it generates
cofactors of activated oxygen radicals during the promotion
of LPO, in presence of Fe3+ and Cu2+ ions [12]. Studies on the
effects of ascorbic acid on erythrocytes during storage have
focused on biochemical parameters, hemolysis and fragility
[13–19].
Rat models provide a platform for rapid experimentation,
in turn forming a basis for further studies on human
models. A comparative study between rat and human
erythrocytes revealed that rat erythrocytes when stored for
1 week in CPDA-1 solution, develop a storage lesion equiva-
lent to that of a lesion formed in human erythrocytes stored
for 4 weeks [20]. Our previous work has elucidated that
reactive oxygen species are maximum on days 10 and 15 of
storage [21] and hence, our current study focuses on the
storage lesion on days 0, 10 and 15 of storage. Therefore this
study aims to evaluate the effects of VC on erythrocytes of
stored rat blood through the following 3 aspects – (i) oxidant
levels of erythrocytes in terms of hemolysis, LPO and
protein oxidation products, (ii) antioxidant enzymes and (iii)
VC as an additive in storage solution.
Materials and methods
Animal care and maintenance was in accordance with
ethical committee regulations.
Chemicals
Hemoglobin (Hb) reagent was obtained from Coral Clinical
Systems, Goa, India. Thiobarbituric acid (TBA), Epinephrine,
Glutathione reductase (GR), Glutathione (GSH) and Bovine
Serum Albumin (BSA) were purchased from Sigma–Aldrich
Chemicals [St. Louis, MO, USA]. All other chemicals used
were of reagent grade and organic solvents were of spectral
grade.Blood sampling
Animals were lightly anaesthetized with ether and
restrained in dorsal recumbancy as described earlier [6]. In
brief, a syringe needle was inserted just below the xyphoid
cartilage and slightly to the left of midline. Four to five
milliliter of blood was carefully aspirated from the heart
into 5 mL plastic collecting tubes with anticoagulant solu-
tion, citrate-phosphate-dextrose-adenine-1 (CPDA-1).
Experimental design
Blood was drawn from Wistar rats (4 months old) and stored
at 4 8C in anticoagulant solution, CPDA-1. Blood samples
were divided into 3 groups – (i) Controls, (ii) VC 10 (samples
with VC as additive at a concentration of 10 mM), (iii) VC 30
(samples with VC as additive at a concentration of 30 mM).
Erythrocytes were isolated from stored blood and the
biomarkers of OS were studied.
Erythrocyte separation
Erythrocytes were isolated by centrifugation for 20 min at
1000  g at 4 8C, plasma and buffy coat were removed using
a micropipette. Cell pellet was washed 3 times and sus-
pended in an equal volume of isotonic phosphate buffer
[22]. This constituted the erythrocyte suspension.
Hb estimation
Hb was measured using Hemocor-D Kit [Coral Clinical
Systems, Goa, India], which utilizes Cyanomethemoglobin
method [23]. Whole blood was incubated with Hb reagent
for 3 min at room temperature and absorbance was mea-
sured colorimetrically at 540 nm. Hb concentration was
represented in terms of g/dL.
Superoxide
Superoxide generated was determined by the method of
Olas and Wachowisz [24]. Cytochrome c (160 mM concentra-
tion) was added to equal volume of sample and incubated
at 37 8C for 5–15 min. Samples were then centrifuged at
3500 rpm for 5 min. Absorbance of the supernatant was
measured at 550 nm.
Antioxidant enzymes
Superoxide dismutase [SOD, EC 1.15.1.1]
SOD was measured by the method of Misra and Fridovich
[25]. Hemolysate was added to carbonate buffer [0.05 M].
Epinephrine was added to the mixture and measured
[ELICO, Model SL 159, India] at 480 nm. SOD activity is
expressed as the amount of enzyme that inhibits oxidation
of epinephrine by 50%.
Catalase [CAT, EC 1.11.1.6]
CAT was determined by the method of Aebi [26]. Briefly,
hemolysate with absolute alcohol was incubated at 0 8C. An
aliquot was taken up with 6.6 mM hydrogen peroxide (H2O2)
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extinction coefficient of 43.6 M cm1 was used to determine
enzyme activity.
Glutathione peroxidase [GSH-Px, EC.1.11.1.9]
GSH-Px was analyzed by the method of Flohe and Gunzler
[27]. Fifty microliters of 0.1 M phosphate buffer (pH 7.0),
100 mL enzyme sample, 100 mL GR (0.24 units), and 100 mL of
10 mM GSH were mixed and pre-incubated for 10 min at
37 8C followed by addition of 100 mL of 1.5 mM b-nicotina-
mide adenine dinucleotide phosphate reduced tetra sodium
salt (NADPH) in 0.1% sodium bicarbonate (NaHCO3). The
overall reaction was started by adding 100 mL of pre-warmed
tert-butyl hydroperoxide and the decrease in absorption at
340 nm was monitored for 3 min.
Hemolysis
A 5% suspension of packed erythrocytes in buffer was mixed
with equal volume of 8 mM H2O2. Mixtures were incubated
at 37 8C in an incubator. Hemolysis was determined by
measuring released Hb into the supernatant of induced
samples at 540 nm and expressed on the basis of maximum
absorbance [100%] in aliquots of erythrocytes completely
hemolysed in distilled water [28].
LPO
Conjugate dienes
Primary marker of LPO, conjugate dienes, was assessed by
the method of Olas and Wachowisz [24]. Briefly, samples
were diluted 5 times in ether:ethanol (1:3, v/v), vortexed for
1 min, centrifuged at 8000 rpm for 20 min and supernatant
was analyzed in a spectrophotometer at 234 nm. Conjugate
dienes produced was calculated using molar extinction
coefficient of 29 500 M1 cm1.
Malondialdehyde (MDA)
MDA, a product of LPO was determined according to the
method of Ohkawa et al. [29]. In brief, hemolysate was
added to 8.1% sodium dodecyl sulfate (SDS), vortexed and
incubated at room temperature. This was followed by the
addition of 20% acetic acid and 0.6% TBA, and placed in
boiling water bath. Samples were allowed to cool and
butanol-pyridine was added and centrifuged. Absorbance
was measured at 532 nm with 1, 1, 3, 3-tetramethoxy
propane as a standard. MDA concentration was expressed
as nmol/mg protein.
Protein oxidation (protein sulfhydryls (P-SH))
P-SH was measured as described by Habeeb [30]. In brief,
0.08 mol/L sodium phosphate buffer containing 0.5 mg/mL
of ethylene diamine tetra acetic acid disodium salt (Na2-
EDTA), and 2% SDS were added to each assay tube. 0.1 mL
of 5,50-dithiobis-(2-nitrobenzoic acid) (DTNB) was also
added. Absorbance was measured at 412 nm. P-SH was
calculated from net absorbance and molar absorptivity,
13 600 mol/L cm1.Ascorbic acid
Ascorbic acid levels were estimated by the method of
Omaye et al. [31]. Briefly, Samples were mixed with equal
volumes of 10% trichloroacetic acid (TCA) and centrifuged at
3500  g for 20 min. Supernatant was mixed with DTC
reagent (2,4-dinitrophenylhydrazine/thiourea/copper sulfate
solution) and incubated for 3 h at 37 8C. Sixty five percent
ice cold sulfuric acid was added and samples were allowed
to stand at room temperature for 30 min. Absorbance was
measured at 520 nm.
Protein determination
Protein was determined in lysate and membrane by the
method of Lowry et al., using BSA as standard [32].
Statistical analyses
Results are represented as mean  standard error (SE).
Values between the groups were analyzed by two-way
analysis of variance (ANOVA) and was considered significant
at P < 0.05. Bonferroni’s Post Test was performed for all
assays using GraphPad Prism 5 software.
Results
Hb
Changes in Hb were insignificant during storage in all
samples with respect to day 0.
Superoxide
Superoxide levels changed significantly as storage pro-
gressed. Superoxide levels reduced with storage by 70% (day
10) and 80% (day 15) against day 0 in controls. Decrements
of 75% (day 10) and 90% (day 15) were observed in VC 10
with day 0. VC 30 also showed decreases in superoxides by
85% (days 10 and 15) against day 0.
Changes between antioxidants were insignificant (Fig. 1).
Antioxidant enzymes
SOD
Significant changes in SOD activity were observed in all
groups with storage. Increments of 150% and 40% were
observed in controls on days 10 and 15 (day 0). SOD activity
in VC 10 increased by 83% and 110% on days 10 and 15
against day 0. VC 30 showed an increase in the SOD activity
on day 10 by 63% with respect to day 0.
SOD varied significantly between antioxidants. SOD
increased in VC 10 by 65% than control while VC 30 showed
lower levels of SOD (40%) than VC 10 on day 15 (Fig. 2).
CAT
Our results showed significant changes in CAT activity with
storage. An increase of 190% (day 10) and 43% (day 15) was
observed in controls against day 0. CAT increased by 100%
Fig. 1 – Superoxide in erythrocytes of stored blood. Values
are expressed as mean W SE from 5 animals. VC 10 –
Vitamin C (10 mM); VC 30 – Vitamin C (30 mM). Changes
were analyzed by two-way ANOVA followed by
Bonferroni’s post-test using GraphPad Prism Software.
P < 0.05 was considered significant. Changes between the
groups are represented in upper case, while changes
within a group are represented in lower case. Those not
sharing the same letters are significant
Fig. 3 – Catalase in erythrocytes of stored blood. Values are
expressed as mean W SE from 5 animals. VC 10 – Vitamin C
(10 mM); VC 30 – Vitamin C (30 mM). Changes were
analyzed by two-way ANOVA followed by Bonferroni’s
post-test using GraphPad Prism Software. P < 0.05 was
considered significant. Changes between the groups are
represented in upper case, while changes within a group
are represented in lower case. Those not sharing the same
letters are significant
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days 10 and 15.
Changes in CAT between antioxidants were significant.
Reductions of 60% (days 10 and 15) were observed in VC 10
and 70% (day 10) were observed in VC 30 against controls
(Fig. 3).
GSH-Px
GSH-Px activity was significant with storage period. There
was an elevation of 220% and 110% on days 10 andFig. 2 – Superoxide dismutase in erythrocytes of stored
blood. Values are expressed as mean W SE from 5 animals.
VC 10 – Vitamin C (10 mM); VC 30 – Vitamin C (30 mM).
Changes were analyzed by two-way ANOVA followed by
Bonferroni’s post-test using GraphPad Prism Software.
P < 0.05 was considered significant. Changes between the
groups are represented in upper case, while changes
within a group are represented in lower case. Those not
sharing the same letters are significant15 respectively in controls (day 0). GSH-Px increased by
52% (day 10) and 280% (day 15) with respect to day 0 in VC
10. GSH-Px activity was higher in VC 30 by 30% on days 10
and 15.
Changes between antioxidants were significant. VC 10
showed a reduction in GSH-Px by 65%, 85% and 40% in
comparison to respective controls on days 0, 10 and 15.
Levels of GSH-Px reduced by 73% and 57% in VC 30 on days
10 and 15, against controls (Fig. 4).Fig. 4 – Glutathione peroxidase in erythrocytes of stored
blood. Values are expressed as mean W SE from 5 animals.
VC 10 – Vitamin C (10 mM); VC 30 – Vitamin C (30 mM).
Changes were analyzed by two-way ANOVA followed by
Bonferroni’s post-test using GraphPad Prism Software.
P < 0.05 was considered significant. Changes between the
groups are represented in upper case, while changes
within a group are represented in lower case. Those not
sharing the same letters are significant
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Significant changes in hemolysis were observed in all
samples against storage. Hemolysis increased by 46% and
65% in controls on days 10 and 15 during storage. Levels of
hemolysis increased in VC 10 and VC 30 by 39% and 43% on
days 10 and 15 respectively.
Changes between antioxidants were insignificant.
LPO
Conjugate dienes
Changes between controls and experimentals during storage
were insignificant.
MDA
MDA was assayed as a measure of LPO and insignificant
changes were observed during storage period. Changes
between groups were insignificant.
Protein oxidation (protein oxidation (P-SH))
Lysate
P-SH was significant with storage. Increases of 86% and
130% were observed on days 10 and 15 in controls. P-SH
reduced by 40% on day 10 while it increased by 35% on day
15 in VC 10 and VC 30.
VC 30 showed rises of 370% (day 0) with control. P-SH
incremented in VC 30 by 200% and 95% on day 15 against
control and VC 10 respectively (Fig. 5).
Membrane
P-SH was insignificant with storage and between groups in
membrane.Fig. 5 – Protein sulfhydryls (hemolysate) in erythrocytes of
stored blood. Values are expressed as mean W SE from 5
animals. VC 10 – Vitamin C (10 mM); VC 30 – Vitamin C
(30 mM). Changes were analyzed by two-way ANOVA
followed by Bonferroni’s post-test using GraphPad Prism
Software. P < 0.05 was considered significant. Changes
between the groups are represented in upper case, while
changes within a group are represented in lower case.
Those not sharing the same letters are significantAscorbic acid
Ascorbic acid varied significantly with storage period. Con-
trols showed increased levels of ascorbic acid on day 10
(150%) and day 15 (30%) against day 0. Ascorbic acid levels
were higher in VC 10 by 50% on day 10. VC 30 showed
higher ascorbic acid on days 10 and 15 (70% and 160%
respectively) against day 0.
Ascorbic acid levels were significant among antioxidants.
Ascorbic acid decremented by 35% in VC 30 against control
on day 10 while it incremented by 85% on day 15 against
respective control and VC 10 (Fig. 6).
Discussion
Hb, the oxygen carrying molecule present in erythrocytes, is
exposed to a constant state of oxygen. Iron (ferrous) present
in Hb, upon exposure to oxygen undergoes autoxidation to
MetHb, which is unable to bind and carry oxygen [33]. This
reaction is a reversible one and Hb can be restored by
several antioxidant mechanisms [34]. Changes in Hb are
indicative of successful conversion of MetHb (formed during
storage) to Hb.
Superoxides (O2
) are produced in erythrocytes either by
auto-oxidation of Hb or by exogenous sources [35, 36]. These
radicals can directly or indirectly affect red cell membranes
[37]. Levels of O2
 decreased in all groups with storage,
indicative of successful scavenging by SOD and interaction
of superoxide in reactive oxygen species (ROS) cascade to
form H2O2, hydroxyl and peroxynitrite [11].
Various endogenous and exogenous mechanisms are
present in order to combat the deleterious effects of OS by
ROS [38]. SOD, CAT and GSH-Px play an important role in
the protection of erythrocytes against oxygen toxicity [39].
The first barrier of defense against superoxide radicals is
SOD – an enzyme which facilitates the dismutation ofFig. 6 – Ascorbic acid in erythrocytes of stored blood. Values
are expressed as mean W SE from 5 animals. VC 10 –
Vitamin C (10 mM); VC 30 – Vitamin C (30 mM). Changes
were analyzed by two-way ANOVA followed by
Bonferroni’s post-test using GraphPad Prism Software.
P < 0.05 was considered significant. Changes between the
groups are represented in upper case, while changes
within a group are represented in lower case. Those not
sharing the same letters are significant
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site [40]. SOD activity was higher on day 10 in accordance
with higher levels of ROS. Decrease of SOD activity upon
progression of storage period can be attributed to reduction
in free radicals which can be due to effective antioxidant
system of erythrocytes. Ascorbic acid itself reacts with
superoxide radicals [41], hence assisting SOD in quenching
superoxide radicals, as observed in the results of VC 30 on
days 10 and 15.
GSH-Px efficiently protects the cell membrane from LPO
and catalyzes reactions of hydroperoxides with GSH to form
glutathione disulfide (GSSG) [42]. GSH-Px enzyme competes
with CAT for H2O2 as a substrate and is a major source of
protection against low levels of OS [43]. CAT mediates the
decomposition of H2O2 through catalytic or peroxidative
mechanisms at high levels of OS [44]. Our study shows
activation of CAT and GSH-Px in all groups in accordance
with SOD activity, to combat H2O2. High levels of CAT and
GSH-Px were observed on day 10 in controls in accordance
with high levels of ROS [21]. Decrease in antioxidant enzyme
activity in control on day 15, may be due to free radical
scavenging activity of antioxidant enzymes and their inhibi-
tion by free radical species [45, 46]. GSH-Px and CAT were
significantly lower in experimental groups and this could be
attributed to radical scavenging effects of VC [8–10], thereby
reducing H2O2 formation.
Erythrocyte membrane is highly susceptible to peroxida-
tive modifications due to large amounts of polyunsaturated
fatty acids, oxygen rich environment and iron rich Hb [11].
Hemolysis is a reliable marker of erythrocyte membrane
stability and increased in all groups indicating that VC could
not protect the membrane from oxidation completely. LPO
is a process that is accelerated by ROS cascade [47] and
causes loss of membrane deformability and integrity, in
turn leading to cell death [11]. Conjugate dienes and MDA
are primary and secondary markers of LPO respectively. As
storage progressed, LPO was insignificant demonstrating
that VC maintained conjugate dienes and MDA.
Protein oxidation occurs due to OS and in erythrocytes,
P-SH are one of the protein oxidation products of great
importance. P-SH can be reversibly or irreversibly modified
based on the extent of oxidative modifications [48]. P-SH
levels increased on day 15 of storage in VC 30, indicative of
the antioxidant effect of ascorbic acid. VC successfully
maintained sulfhydryl levels during storage.
Ascorbic acid was analyzed to determine the utilization
of the added VC during storage. Ascorbic acid levels
increased on day 15 in VC 30, showing early utilization of
VC in erythrocyte antioxidant defense.
Conclusion
VC assisted erythrocytes by scavenging free radicals, activat-
ing antioxidant enzymes and maintaining Hb, LPO and
protein oxidation products. VC at a concentration of 30 mM
decreased SOD levels and increased P-SH levels on day 15
showing that higher concentration supplemented the inher-
ent antioxidant defense system of erythrocytes and pro-
tected them against OS during storage. Our findings give aninsight into the effects of VC as an additive in blood storage
solutions. This study forms a basis for further investigations
of effective blood storage solutions.
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